Consultant picture | Picture supplied by: Getty Photographs/iStockphoto
The Union well being ministry has been requested to analyze repeated recollects of batches of disposable syringes on the All India Institute of Medical Sciences (AIIMS) in New Delhi and the potential affect on affected person security.
In a letter to Union Well being Minister JP Nadda on Wednesday (June 10, 2026), Rajya Sabha Haris Veeran mentioned two separate recall notices had been issued inside three weeks for disposable 10ml syringes with needles provided by totally different producers final month attributable to quality-related complaints.
He mentioned, “This growth has raised considerations in regards to the security and high quality assurance protocols of medical units in main healthcare establishments. The notification issued by Hospital Shops, AIIMS consists of the primary recall notification dated Could 5, 2026, and M/s Noble Pharmacare “We’re directing you to return the batch quantity 10DSR243 manufactured by Edgex Restricted inside 48 hours. This discover has been issued in response to complaints relating to the standard of the product.” Syringes provided to the laboratory.
In a subsequent communication dated Could 26, 2026, AIIMS ordered the recall of one other batch No.260433 manufactured by M/s Veekay Surgicals Pvt. Ltd. Ltd. once more cited considerations relating to the standard of the product and directed its instant return from use.
“Successive recall orders involving two totally different suppliers elevate questions in regards to the procurement oversight, inspection mechanisms and high quality management checks that govern the availability of crucial medical consumables in public healthcare establishments. Syringes are one of the vital regularly used disposable medical units in hospitals and are thought-about crucial to an infection management and affected person security,” mentioned Beelan.
Stating that any compromise within the high quality of such units might expose sufferers to critical well being dangers, together with infections and procedural problems, Commissioners mentioned the recurring nature of complaints has elevated scrutiny of present regulatory and oversight frameworks.
He requested the Ministry of Well being for an in depth and time-bound investigation report into the circumstances that led to the issuance of the recall discover, and to establish the particular defects reported within the affected batches. “We have to take into account assessing whether or not there are any sufferers who’ve been adversely affected,” he added.
Moreover, immediate corrective and corrective actions are required to make sure accountability and strengthen high quality assurance programs.
“Given the sensitivity of the matter and its affect on public well being, the main focus is on sustaining transparency and defending affected person welfare throughout the nation’s healthcare amenities,” he mentioned.
